Pharmacy Trial Program

This page provides information about the Pharmacy Trial Program.

Page last updated: 27 September 2018

Background
Principles for the Pharmacy Trial Program
Tranche 1 of the PTP
Tranche 2 of the PTP
Tranche 3 of the PTP
Stakeholder Engagement
Trial Advisory Group
Contacts and relevant links

Background

The Australian Government recognises the important role that pharmacists and pharmacies play in our health system and is committed to supporting pharmacies across Australia in providing consumer access to Pharmaceutical Benefits Scheme (PBS) medicines and effective health care services.

The PBS Access and Sustainability Package is a group of measures which will deliver funding for community pharmacy through the Sixth Community Pharmacy Agreement (Sixth Agreement).

The total funding allocated for community pharmacy programs is $1.26 billion over five years, (2015-16 to 2019-20). This includes:
  • $613 million to support community pharmacy programs that are continuing from the Fifth Community Pharmacy Agreement;
  • $50 million to support a Pharmacy Trial Program (PTP), which seeks to improve clinical outcomes for patients and/or utilise the full scope of a pharmacists role in delivering primary health care services; and
  • $600 million to support a range of new and/or expanded programs.
It is intended that a particular focus of the new, continuing and expanded Community Pharmacy Programs will be those which benefit:
    (a) Aboriginal and Torres Strait Islander peoples; and
    (b) consumers in rural and remote areas.

Principles for the Pharmacy Trial Program

A suite of Principles (PDF 23 KB) - Principles (Word 23 KB), underpin the PTP and trials that are funded.

Tranche 1 of the PTP

Tranche 1 of the PTP involves topics identified from previous research and development work undertaken under previous community pharmacy agreements or through discussions and negotiations on the PBS Access and Sustainability Measure.

Current trials:

Trial name: Indigenous medication review service feasibility study (The IMeRSe Study)
Lead Organisation: The Pharmacy Guild of Australia
Partner organisation/s: National Aboriginal Community Controlled Health Organisation and Griffith University
Description: The feasibility study aims to optimise a patient's medication management via a culturally responsive service, which is being delivered by community pharmacists integrated with Aboriginal Health Services (AHS). The feasibility study involves nine AHS and over 500 patients.
Trial location/s: Queensland, New South Wales and the Northern Territory.

Trial name: Pharmacy diabetes screening
Lead Organisation: The Pharmacy Guild of Australia
Partner organisation/s: University of Sydney and Deakin University
Description: This trial aims to aid in the prevention of type-2 diabetes through early detection, education and referral. Pharmacists assessed a patient’s risk of developing diabetes and referred the patient, where appropriate. Throughout the trial, over 330 pharmacies screened over 14,000 patients.
Trial location/s: National.

Grant Guidelines for Tranche 1 of the PTP

Word version of the Grant Guidelines for Tranche 1 of the PTP (Word 84 KB)
PDF version of the Grant Guidelines for Tranche 1 of the PTP (PDF 277 KB)

Tranche 2 of the PTP

Priority themes for Tranche 2 of the PTP were developed following a stakeholder consultation process.

Current trials:

Trial name: Reducing Medicine Induced Deterioration and Adverse Reactions
Lead Organisation: University of South Australia
Partner organisation/s: Several organisations, including Terry White Chemmart, Southern Cross Care and Helping Hand Aged Care
Description: The service enables early identification of signs and symptoms of medicine induced deterioration, through pharmacists assessing the patient’s medication regimen in aged care facilities. The trial involves 500 patients in residential aged care facilities.
Trial location/s: South Australia and Tasmania.

Trial name: Integrating practice pharmacists into Aboriginal Community Controlled Health Services (The IPAC Project)
Lead Organisation: Pharmaceutical Society of Australia
Partner organisation/s: National Aboriginal Community Controlled Health Organisation and James Cook University
Description: The pharmacist will provide medication management services to Aboriginal and Torres Strait Islander people and support other health professionals in providing these evidence based services. This trial will involve 22 Aboriginal Community Controlled Health Service sites and 10 FTE pharmacists.
Trial location/s: Victoria, Queensland and the Northern Territory.

Trial name: Getting asthma under control
Lead Organisation: Woolcock Institute of Medical Research
Partner organisation/s: Several organisations, including the Pharmacy Guild of Australia, Pharmaceutical Society of Australia, the National Asthma Council, University of Sydney, Curtin University and University of Tasmania
Description: Pharmacists identified patients with uncontrolled asthma and helped them better manage their medication use and inhaler technique. The trial is being undertaken across 80 community pharmacies, with over 550 patients expected to be recruited.
Trial location/s: New South Wales, Western Australia and Tasmania.

Trial name: Cardiovascular disease risk factors
Lead Organisation: Black Swan Health
Description: The trial is for an integrated health check delivered in community pharmacy to detect risk, diagnose and enable early intervention for cardiovascular disease (CVD). The community pharmacy will be well integrated with general practice and other providers to ensure individuals with elevated risk status are offered appropriate treatment to reduce their overall CVD risk and improve quality of care. The trial will take place in a minimum of 10, and up to 20, community pharmacies. The trial is expected to reach more than 3,000 patients.
Trial location/s: Perth.

Grant Guidelines for Tranche 2 of the PTP can be accessed via Grant Connect.

Tranche 3 of the PTP

Further trials:

Trial name: Chronic Pain MedsCheck trial
Lead Organisation: The Pharmacy Guild of Australia and Pharmaceutical Society of Australia
Partner organisation/s: HealthConsult and University of South Australia
Description: The trial will assist patients who are taking medication to manage ongoing chronic pain for three months or more and are experiencing self management issues or who have dependency issues. The trial will involve professional pharmacist face to face consultations with patients to review their medication use and develop a written action plan, incorporating education, self management and referral to a GP or other health professional where additional support is required. All community pharmacies are eligible to participate in the trial.
Trial location/s: National.


Stakeholder Engagement

Stakeholder involvement, input and support from the consumer, pharmacy, pharmaceutical and medical sectors have been essential in assisting the Department in designing and implementing the PTP, and determining trial priorities.

The consultation process for the PTP commenced with a public forum on 26 October 2015, which a number of national peak groups and stakeholders attended. Please see the Forum Report (PDF 68 KB) - Forum Report (Word 33 KB).

The Department released a Discussion Paper (PDF 230 KB) - Discussion Paper (Word 362 KB), between 17 March 2016 and 29 April 2016 with a high level ‘Call for Ideas’ from stakeholders. The Department received 108 responses to the consultation process. The information collected through the consultation process was used to develop priority themes for the PTP for consideration by the Minister for Health.

Trials Advisory Group

The Trial Advisory Group (TAG) was established as an independent expert advisory committee to provide advice to the Department on the development and implementation of trials under the PTP.

More information is available on the Trials Advisory Group page.

Contact Us

If you wish to contact the Department in relation to the PTP, you can do so via the Pharmacy Trial Programme email address: (pharmacy.trial.programme@health.gov.au).

Relevant Links